$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Boston Scientific Corporation (BSX) Is Worth Thinking About For The Coming Weeks
09:00pm, Thursday, 18'th Nov 2021 Stocks Register
Boston Scientific Corporation (NYSE:BSX) price on Thursday, November 18, fall -1.05% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $41.17. A look at the stock’s price movement, the level at last check in today’s session was $41.61, moving within a range at $41.385 and $42.02. The beta … Boston Scientific Corporation (BSX) Is Worth Thinking About For The Coming Weeks Read More »
Atalanta Sosnoff Capital, Llc Buys American Express Co, Boston Scientific Corp, Comcast Corp, ...
04:38pm, Thursday, 18'th Nov 2021 GuruFocus
Related Stocks: CMCSA , BSX , ATVI , ANTM , COP , EOG , AXP , MRK , CMA , AAP , M , GE , SLB , STZ , NSC , MS , PYPL , ADBE , UNP , TMUS , PPG , SIX , VFC , OLED ,
David S. Wichmann Buys 25,000 Shares of Boston Scientific Co. (NYSE:BSX) Stock
09:58am, Thursday, 18'th Nov 2021 Dakota Financial News
Boston Scientific Co. (NYSE:BSX) Director David S. Wichmann purchased 25,000 shares of the firms stock in a transaction on Monday, November 15th. The stock was bought at an average cost of $41.98 per share, with a total value of $1,049,500.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which []
Pacemakers Market to Undertake Strapping Growth by the End 2031 | Growth Plus Reports
09:18am, Thursday, 18'th Nov 2021 Benzinga
Pune, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The Global Pacemakers Market is expected to clock US$ ~6.06 billion by 2031 owing to the rising prevalence of cardiovascular diseases and technological advancements in pacemaker devices. Request sample PDF of this report at: https://growthplusreports.com/product/pacemaker-market Growth Factor Various government and private organizations across the globe are providing the necessary fundings and grants in order to encourage R&D in pacemakers. For instance, in November 2019, Texas Heart Institute (THI) was awarded a prestigious four-year, US$ 2.39 million grant from the National Institutes of Health (NIH) to support the further development of a novel pacemaker system that is both leadless and wirelessly powered. The global pacemakers market has been analyzed from four different perspectivesImplantability, Technology, End User, and Region. Excerpts from By Implantability Segmentation'' The global pacemakers market has been segmented majorly into two distinct categories depending on implantability, viz. implantable pacemaker and external pacemaker.
OLD Dominion Capital Management Inc. Has $1.65 Million Holdings in Boston Scientific Co. (NYSE:BSX)
06:26pm, Wednesday, 17'th Nov 2021 Dakota Financial News
OLD Dominion Capital Management Inc. boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX) by 1.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,960 shares of the medical equipment providers stock after purchasing an additional 450 shares during the period. []
The New Report "Pain Management Devices Market" published by Reports Intellect, covers the competitive landscape analysis and its growth prospects over the coming years. An in-depth study of some new and prominent industry trends, analysis of engagement, and regional analysis
Nephroureteral Stent Market Research Study, Future Prospects and Growth Drivers to 2027 | Top Key Vendors - Boston Scientific, C. R. Bard, Cook Medical
11:58am, Wednesday, 17'th Nov 2021 OpenPR
The global Nephroureteral Stent market will grow at a CAGR of 5.77% from 2021 to 2027. A Nephroureteral Stent is a peculiarly designed thin hollow tube inserted into the ureter to avert or cure any kind of impediment in the
Data Bridge Market research presents the top quality and comprehensive Ablation technology research report which provides clear insights into market dynamics and prospects the whole market including global production, revenue forecast, value and volume. This Ablation technology report deeply
Global Transcatheter Aortic Valve Replacement (TAVR) Market Synopsis: DBMR team offers customization of Transcatheter Aortic Valve Replacement (TAVR) Market report according to the business needs. Contact sales team, who will guarantee to get a report that suits the necessities. The Market
The Laparoscopic Power Morcellator Market research report includes a thorough assessment of the industry supply chain by uncovering the top manufacturers, raw material & equipment suppliers, and downstream clients. It also infers the investment viability of a new project by
The micro catheters market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1171.77 million by 2028 and is expected grow at a CAGR
Xylose Absorption Test to Boost the Revenue over the Forecast Period (2021-2027)|Boston Scientific, Pfizer, Mylan Pharmaceuticals
09:30am, Tuesday, 16'th Nov 2021 OpenPR
Market Snapshot A recently published report by QY Research, titled Global Xylose Absorption Test Market Size, Status and Forecast 2022 gives an overview of the overall Xylose Absorption Test market. This section sheds light on key impact-rendering drivers and constraints
Anti-venom Market Consumption, Demand, Supply and Outlook 2027 | Key Companies Boston Scientific, Bharat Serums and Vaccines, Merck, Flynn Pharma, Pfizer
08:49am, Tuesday, 16'th Nov 2021 OpenPR
Anti-venom Market 2021 The global Anti-venom Market research report provides an in-depth analysis of the industry''s current and future situation. The study, which was completed utilizing extensive primary and secondary research, has all of the necessary market data. The report includes
Market Intelligence Data has released a new report on the global “Metal Partially Covered Biliary Stent market”. The document gives a complete evaluation of the market. It understands market development through in-depth insights, tracking historical results and analysing current scenarios
Analyst Predictions On Boston Scientific Corporations (NYSE: BSX) Future Growth
07:00pm, Monday, 15'th Nov 2021 Stocks Register
Boston Scientific Corporation (NYSE:BSX) price is hovering lower on Monday, November 15, dropping -0.92% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Sign In
Buy BSX